Compound Information | SONAR Target prediction | Name: | ERYTHROMYCIN ETHYLSUCCINATE | Unique Identifier: | SPE01500279 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | | Molecular Weight: | 786.457 g/mol | X log p: | -2.199 (online calculus) | Lipinksi Failures | 2 | TPSA | 145.36 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 17 | Rotatable Bond Count: | 14 | Canonical Smiles: | CCOC(=O)CCC(=O)OC1C(CC(C)OC1OC1C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(=O)O C(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC1(C)O)N(C)C | Source: | semisynthetic | Therapeutics: | antibacterial |
Species: |
4932 |
Condition: |
TEP1 |
Replicates: |
2 |
Raw OD Value: r im |
0.6449±0.00636396 |
Normalized OD Score: sc h |
0.9732±0.00270989 |
Z-Score: |
-0.7186±0.115948 |
p-Value: |
0.473892 |
Z-Factor: |
-2.16693 |
Fitness Defect: |
0.7468 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 12|A5 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 26.40 Celcius | Date: | 2005-12-23 YYYY-MM-DD | Plate CH Control (+): | 0.040225±0.00215 | Plate DMSO Control (-): | 0.63205±0.01530 | Plate Z-Factor: | 0.9068 |
| png ps pdf |
DBLink | Rows returned: 6 | |
3256 |
ethyl [4-dimethylamino-2-[[14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,7 ,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradec-6-yl]oxy]-6-methyl-oxan-3-yl] butanedioate |
14750 |
ethyl [(2R,3S,4R,6S)-4-dimethylamino-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2 S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacycl otetradec-6-yl]oxy]-6-methyl-oxan-3-yl] butanedioate |
38844 |
ethyl [4-dimethylamino-2-[[(3R,4S,6R,7R,9R,11R,12R,13R,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy -4,6-dimethyl-oxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradec-6-yl]oxy]-6-methyl-ox an-3-yl] butanedioate |
443953 |
ethyl [(2S,3R,4S,6R)-4-dimethylamino-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2 S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacycl otetradec-6-yl]oxy]-6-methyl-oxan-3-yl] butanedioate |
456507 |
ethyl [4-dimethylamino-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-meth oxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradec-6-yl]oxy]-6-methyl -oxan-3-yl] butanedioate |
16049797 |
[(2S,3R,4S,6R)-4-dimethylamino-2-[[(3R,4S,5R,6R,7S,9R,11R,12S,13R,14R)-14-ethyl-7,12-dihydroxy-4-[(2R,4R ,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotet radec-6-yl]oxy]-6-methyl-oxan-3-yl] ethyl butanedioate |
internal high similarity DBLink | Rows returned: 1 | |
|